Chemring Group - CHG Share Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemring Group in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CHG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHG, but not buy additional shares or sell existing shares.
View CHG analyst ratings or view top-rated stocks.

2 brokerages have issued 12-month target prices for Chemring Group's shares. Their CHG share price forecasts range from GBX 336 to GBX 380. On average, they predict the company's share price to reach GBX 358 in the next year. This suggests a possible upside of 27.0% from the stock's current price.
View analysts price targets for CHG or view top-rated stocks among Wall Street analysts.

Chemring Group's stock was trading at GBX 297.50 at the beginning of the year. Since then, CHG shares have decreased by 5.2% and is now trading at GBX 282.
View the best growth stocks for 2023 here.

Chemring Group PLC (LON:CHG) posted its quarterly earnings results on Thursday, January, 17th. The company reported $6.90 earnings per share for the quarter, missing the consensus estimate of $8.70 by $1.80.

Chemring Group declared a dividend on Wednesday, December 13th. Shareholders of record on Thursday, March 23rd will be paid a dividend of GBX 3.80 per share on Friday, April 14th. This represents a dividend yield of 1.27%. The ex-dividend date of this dividend is Thursday, March 23rd. This is a boost from the stock's previous dividend of GBX 1.90. The official announcement can be viewed at this link.
Read our dividend analysis for CHG.

Chemring Group (LON:CHG) pays an annual dividend of GBX 0.05 per share and currently has a dividend yield of 2.05%. The dividend payout ratio is 31.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CHG.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemring Group investors own include Avon Protection (AVON), KAZ Minerals (KAZ), Barclays (BARC), Celanese (CE), Avesoro Resources (ASO), Avesoro Resources (ASO), Hawaiian (HA), KCOM Group (KCOM), Unilever (ULVR) and Alpine Immune Sciences (ALPN).

Chemring Group trades on the London Stock Exchange (LON) under the ticker symbol "CHG."

Shares of CHG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CHG stock can currently be purchased for approximately GBX 282.

Chemring Group (LON:CHG) has a market capitalization of £799.65 million and generates £415.20 million in revenue each year.

The company employs 2,255 workers across the globe.

Chemring Group's mailing address is Roke Manor, Old Salisbury Lane, ROMSEY, SO51 0ZN, United Kingdom. The official website for the company is www.chemring.co.uk. The company can be reached via phone at +44-1794-833901.